Table 3.
Univariate Analysis of Clinical and MRI Parameters Between Survivors and Non-Survivors in Group A (n = 39).
| Variable | Survivors (n = 21) | Non-survivors (n = 18) | Odds ratio | 95% CI | P value |
|---|---|---|---|---|---|
| Age (years) | 43.6 (26–58)* | 41.6 (24–70) | 0.965 | 0.896–1.041 | 0.481 |
| MELD | 22.8 (16–25) | 33.7 (17–50) | 1.29 | 1.115–1.512 | 0.001 |
| CLIF-SOFA | 7.7 (4–11) | 11.2 (6–17) | 1.777 | 1.226–2.577 | 0.002 |
| APACHE II | 7.7 (3–25) | 11.2 (3–27) | 1.153 | 1.024–1.299 | 0.028 |
| MD value (×10−9 M2/s) | |||||
| FWM | 8.2 (7.8–8.7) | 8.9 (7.3–10.8) | 7.858 | 2.079–29.698 | 0.002 |
| PWM | 8.3 (7.5–8.9) | 8.3 (7.8–10.9) | 1.126 | 0.273–4.642 | 0.535 |
| ALIC | 7.8 (7.1–8.7) | 7.9 (7.2–8.9) | 1.216 | 0.297–4.96 | 0.588 |
| Genu (IC) | 7.7 (7.1–8.5) | 8.3 (7.6–9.8) | 3.852 | 1.168–12.710 | 0.027 |
| PLIC | 7.5 (7.2–7.9) | 7.9 (7.1–10.8) | 3.718 | 0.977–14.149 | 0.04 |
| BG | 8.4 (8.1–8.6) | 9.2 (8.3–9.5) | 4.483 | 1.483–13.557 | 0.008 |
*
Mean (95% confidence interval). MELD, model for end stage liver disease; CLIF-SOFA, chronic liver failure sequential organ failure assessment score; APACHE II, acute physiology and chronic health evaluation II; MD, mean diffusivity; FWM-frontal white matter; PWM-parietal white matter; ALIC-anterior limb of internal capsule IC, internal capsule; PLIC, posterior limb of internal capsule; BG, basal ganglia.